Minnesota Senate Bill SF4940

Minnesota 2025-2026 Regular Session

• Introduced: 4/7/26
• Refer: 4/7/26

Caption

Coverage of medical services and prescription medications requirement for the treatment of dementia

Impact

The bill also modifies existing requirements related to step therapy protocols, which are often criticized for unnecessarily delaying access to needed medications. Under SF4940, health plan companies will not be permitted to utilize step therapy for the treatments mandated by the bill. This change is expected to improve patient care and outcomes by allowing doctors to make decisions about treatment based on individual patient needs rather than adhering to potentially burdensome protocols. Moreover, the bill establishes that these provisions will take effect for health plans offered, issued, or renewed after January 1, 2027, suggesting that a transition period is in place for health insurers.

Summary

SF4940 aims to enhance health insurance coverage for individuals suffering from dementia by mandating that health plan companies provide comprehensive coverage for all medical services and prescription medications approved for treating or slowing the progression of this condition. This bill is particularly significant because it addresses a growing public health concern, as dementia rates are on the rise. The requirement for coverage includes necessary diagnostic testing to evaluate treatment effectiveness. By doing so, the bill seeks to ensure that patients have access to essential care without undue restrictions.

Contention

While supporters of SF4940 argue that this legislation is crucial for improving the quality of life for those affected by dementia, there are concerns among some stakeholders regarding the potential increase in costs for insurance providers. Opponents may argue that such mandates could result in higher premiums for all policyholders, creating a financial strain on health insurance systems. The balance between improving patient care for specialized needs like dementia treatment and maintaining affordability in health insurance is a central point of contention in discussions surrounding this bill.